Skip to content

Advertisement

Open Peer Review Reports for: Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
13 Jan 2017 Submitted Original manuscript
7 Feb 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 2
7 Feb 2017 Submitted Manuscript version 2
1 May 2017 Reviewed Reviewer Report - David F Jarrard
25 Jun 2017 Reviewed Reviewer Report - Klaus Brasso
13 Jul 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 3
13 Jul 2017 Submitted Manuscript version 3
18 Jul 2017 Reviewed Reviewer Report - Klaus Brasso
8 Aug 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 4
8 Aug 2017 Submitted Manuscript version 4
14 Sep 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 5
14 Sep 2017 Submitted Manuscript version 5
6 Oct 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 6
6 Oct 2017 Submitted Manuscript version 6
30 Oct 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 7
30 Oct 2017 Submitted Manuscript version 7
Publishing
6 Nov 2017 Editorially accepted
10 Nov 2017 Article published 10.1186/s12885-017-3755-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement